Regression and therapy of atherosclerosis: drug therapy of atherosclerosis viewed from serum lipoprotein analysis--reality of application, choice and administration of anticholesteremic agents
Nakamura, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 710-716
1988
ISSN/ISBN: 0047-1852 PMID: 3404699 Document Number: 322130
Document emailed within 1 workday
Related Documents
1990: Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group JAMA 264(23): 3018-3024Kawamura, M.; Naito, C. 1988: Progress in the study of lipoprotein metabolism and atherosclerosis: role of blood lipoproteins and pathogenesis of atherosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 621-628
Buchborn, E.; Weber, P.C. 1989: Atherosclerosis--prevention and drug therapy Der Internist 30(5): 273-275
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Hedstrand, H. 1970: Serum-lipid reducing principles--possibilities for treatment. 4. Diet therapy for atherosclerosis Lakartidningen 67: Suppl Iv: 53+
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Tamachi, H.; Goto, Y. 1988: Progress in the study of lipoprotein metabolism and atherosclerosis: organ-specific characteristics of lipoprotein metabolic disorders--with special reference to the heart and brain Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 671-678
Thomas, D.; Richard, J.L.; Emmerich, J.; Bruckert, E.; Delahaye, F. 1992: Is regression of atherosclerosis possible? Archives des Maladies du Coeur et des Vaisseaux 85(Special Issue 3): 47-57
Gajdos, M.; Cagán, S.; Spustová, V.; Dzúrik, R. 1996: Prevention and therapy of atherosclerosis Bratislavske Lekarske Listy 97(7): 382-387
Weber, G.; Resi, L.; Tanganelli, P. 1989: Regression of atherosclerosis lesions Wiener Klinische Wochenschrift 101(20): 698-702
Follath, F.; Drexel, H. 1991: Is regression of atherosclerosis by drugs possible? Schweizerische Medizinische Wochenschrift 121(49): 1803-1806
Sasaki, J. 2011: Exercise therapy for prevention of atherosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 69(1): 119-124
Punnonen, R.; Jokela, H.; Heinonen, P.K.; Aine, R.; Dastidar, P. 1995: Hormone replacement therapy and atherosclerosis Journal of Reproductive Medicine 40(4): 267-272
Liping, Z.; Xiufang, L.; Tao, Y.; Baomin, Z.; Houshuai, T. 2018: Efficacy comparison of rosuvastatin and atorvastatin in the treatment of atherosclerosis and drug safety analysis Pakistan Journal of Pharmaceutical Sciences 31(5(Special): 2203-2208
Yuzawa, Y.; Watanabe, Y.; Yoshida, F.; Hiramatsu, T.; Aoi, N.; Matsuo, S.; Sakamoto, N. 1987: Quantitative analysis of atherosclerosis in chronic hemodialysed patients--clinical application of aortic pulse wave velocity Nihon Jinzo Gakkai Shi 29(10): 1261-1269
Bruschke, A.V.; Jukema, J.W.; Van der Wall, E.E. 1993: Progression and regression of coronary atherosclerosis Indian Heart Journal 45(4): 259-264
Danese, C.; Borgia, M.C.; Ferranti, E.; Zavattaro, E.; Epiceno, A.N.; Marcianó, F. 1996: Lipoprotein (a) and plasminogen in atherosclerosis Minerva Cardioangiologica 44(11): 529-533
Misra, A. 1999: Atherosclerosis in Indians and lipoprotein (a) Journal of the Association of Physicians of India 47(3): 313-317
Gaton, E.; Wolman, M. 1984: Macrophage activation in the prevention or regression of atherosclerosis Advances in Experimental Medicine and Biology 168: 15-36
Seidel, D. 1995: Impact of lipids on progression and regression of atherosclerosis Transplantation Proceedings 27(3): 2057-2061